Gene: Cyp4a8 (cytochrome P450, family 4, subfamily a, polypeptide 8) Rattus norvegicus
Analyze
No known orthologs.
Symbol:
Cyp4a8
Name:
cytochrome P450, family 4, subfamily a, polypeptide 8
RGD ID:
628846
Description:
Enables fatty acid omega-hydroxylase activity. Involved in fatty acid metabolic process; kidney development; and response to testosterone. Located in endoplasmic reticulum membrane. Biomarker of autosomal recessive polycystic kidney disease and hypertension. Human ortholog(s) of this gene implicated in hypertension. Orthologous to human CYP4A11 (cytochrome P450 family 4 subfamily A member 11) and CYP4A22 (cytochrome P450 family 4 subfamily A member 22); PARTICIPATES IN arachidonic acid metabolic pathway; eicosanoid signaling pathway via peroxisome proliferator-activated receptor gamma; fatty acid metabolic pathway; INTERACTS WITH 17beta-estradiol; 2,2',4,4'-Tetrabromodiphenyl ether; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
Cyp4a12; CYPIVA12; CYPIVA8; cytochrome P450 4A12; cytochrome P450, 4a12; cytochrome P450-KP1; cytochrome P450-PP1; MGC93354; P450-KP1; P450-PP1
RGD Orthologs
Alliance Orthologs
More Info
homologs ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Other homologs 2
Homo sapiens (human):
CYP4A22 (cytochrome P450 family 4 subfamily A member 22)
HGNC
HomoloGene, OrthoDB, Panther, PhylomeDB, Treefam
Homo sapiens (human):
CYP4A11 (cytochrome P450 family 4 subfamily A member 11)
HGNC
OrthoDB, Panther, PhylomeDB, Treefam
Homo sapiens (human):
FGFBP3 (fibroblast growth factor binding protein 3)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
CYP4A11 (cytochrome P450 family 4 subfamily A member 11)
Alliance
DIOPT (Ensembl Compara|Hieranoid|OMA|OrthoFinder|PANTHER|PhylomeDB)
Mus musculus (house mouse):
Cyp4a12a (cytochrome P450, family 4, subfamily a, polypeptide 12a)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
CYP4A22 (cytochrome P450 family 4 subfamily A member 22)
Alliance
DIOPT (Ensembl Compara|Hieranoid|OMA|OrthoFinder|PANTHER|PhylomeDB)
Mus musculus (house mouse):
Cyp4a12b (cytochrome P450, family 4, subfamily a, polypeptide 12B)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp4t8 (cytochrome P450, family 4, subfamily T, polypeptide 8)
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
cyp4b1.2
Alliance
DIOPT (Ensembl Compara|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
cyp4b1.3
Alliance
DIOPT (Ensembl Compara|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
cyp4b1
Alliance
DIOPT (Ensembl Compara|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
cyp4b1.5
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Related Pseudogenes:
Cyp4a8-ps1
Candidate Gene For:
Rf54
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 133,938,882 - 133,970,226 (-) NCBI GRCr8 mRatBN7.2 5 128,702,130 - 128,733,476 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 128,702,131 - 128,733,476 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 131,384,778 - 131,406,871 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 133,114,432 - 133,136,521 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 133,136,126 - 133,158,217 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 133,978,953 - 134,008,255 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 133,978,954 - 134,008,255 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 137,769,865 - 137,799,167 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 135,546,858 - 135,578,199 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 135,552,083 - 135,583,425 (-) NCBI Celera 5 127,340,416 - 127,371,735 (-) NCBI Celera Cytogenetic Map 5 q35 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cyp4a8 Rat 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CYP4A8 mRNA CTD PMID:32145629 Cyp4a8 Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP4A8 mRNA CTD PMID:27291303|PMID:32679240 Cyp4a8 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP4A8 mRNA CTD PMID:21215274|PMID:32387183 Cyp4a8 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4A8 mRNA CTD PMID:21724226|PMID:33387578 Cyp4a8 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... CTD PMID:36041667 Cyp4a8 Rat 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYP4A8 mRNA CTD PMID:31881176 Cyp4a8 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CYP4A8 mRNA CTD PMID:28959563 Cyp4a8 Rat aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CYP4A8 mRNA CTD PMID:23630614|PMID:33354967 Cyp4a8 Rat alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of CYP4A8 mRNA CTD PMID:17785943 Cyp4a8 Rat amiodarone affects expression EXP 6480464 Amiodarone affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP4A8 mRNA CTD PMID:16483693 Cyp4a8 Rat anthracen-2-amine decreases expression EXP 6480464 2-anthramine results in decreased expression of CYP4A8 mRNA CTD PMID:23038007 Cyp4a8 Rat benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP4A8 mRNA CTD PMID:18164116 Cyp4a8 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP4A8 mRNA CTD PMID:30903817|PMID:32145629 Cyp4a8 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... CTD PMID:36041667 Cyp4a8 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... CTD PMID:36041667 Cyp4a8 Rat clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP4A8 mRNA CTD PMID:12851107 Cyp4a8 Rat clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CYP4A8 mRNA CTD PMID:18670166 Cyp4a8 Rat copper atom decreases expression EXP 6480464 Copper results in decreased expression of CYP4A8 mRNA CTD PMID:22465980 Cyp4a8 Rat copper(0) decreases expression EXP 6480464 Copper results in decreased expression of CYP4A8 mRNA CTD PMID:22465980 Cyp4a8 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of CYP4A8 mRNA CTD PMID:26577399 Cyp4a8 Rat D-gluconic acid multiple interactions EXP 6480464 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of CYP4A8 mRNA CTD PMID:16556975 Cyp4a8 Rat deoxycholic acid multiple interactions EXP 6480464 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of CYP4A8 mRNA CTD PMID:16556975 Cyp4a8 Rat dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CYP4A8 mRNA CTD PMID:20832446 Cyp4a8 Rat fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP4A8 mRNA CTD PMID:18253720 Cyp4a8 Rat fipronil decreases expression EXP 6480464 fipronil results in decreased expression of CYP4A8 mRNA CTD PMID:23962444 Cyp4a8 Rat formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of CYP4A8 mRNA CTD PMID:12679049 Cyp4a8 Rat furan decreases expression EXP 6480464 furan results in decreased expression of CYP4A8 mRNA CTD PMID:25539665|PMID:26194646 Cyp4a8 Rat hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of CYP4A8 mRNA CTD PMID:15159207 Cyp4a8 Rat indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP4A8 mRNA CTD PMID:22129741 Cyp4a8 Rat indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of CYP4A8 mRNA CTD PMID:36868495 Cyp4a8 Rat L-ethionine affects expression EXP 6480464 Ethionine affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of CYP4A8 mRNA CTD PMID:15644446 Cyp4a8 Rat Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP4A8 mRNA CTD PMID:21515302 Cyp4a8 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP4A8 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] more ... CTD PMID:18164116|PMID:18253720|PMID:22129741|PMID:28943392 Cyp4a8 Rat ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CYP4A8 mRNA CTD PMID:17483316 Cyp4a8 Rat omeprazole affects expression EXP 6480464 Omeprazole affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of CYP4A8 mRNA CTD PMID:23665939 Cyp4a8 Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP4A8 protein CTD PMID:34958885 Cyp4a8 Rat phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP4A8 mRNA CTD PMID:19162173 Cyp4a8 Rat pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP4A8 mRNA CTD PMID:19162173 Cyp4a8 Rat riddelliine decreases expression EXP 6480464 riddelliine results in decreased expression of CYP4A8 mRNA CTD PMID:18047727 Cyp4a8 Rat sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of CYP4A8 mRNA CTD PMID:25993096 Cyp4a8 Rat Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP4A8 mRNA CTD PMID:21515302 Cyp4a8 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYP4A8 mRNA CTD PMID:17805973|PMID:31150632 Cyp4a8 Rat thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of CYP4A8 mRNA CTD PMID:19483382 Cyp4a8 Rat thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP4A8 mRNA CTD PMID:28943392 Cyp4a8 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP4A8 mRNA CTD PMID:23411599|PMID:34492290 Cyp4a8 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP4A8 mRNA CTD PMID:33387578 Cyp4a8 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CYP4A8 mRNA CTD PMID:30589522 Cyp4a8 Rat troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP4A8 mRNA CTD PMID:21515302
Molecular Function
Only show annotations with direct experimental evidence (0 objects hidden)
Cyp4a8 Rat alkane 1-monooxygenase activity enables IBA MGI:88612|PANTHER:PTN000669780|RGD:2479|RGD:631356|RGD:68945|UniProtKB:Q02928 1600115 GO_REF:0000033 GO_Central GO_REF:0000033 Cyp4a8 Rat arachidonate monooxygenase activity enables IBA PANTHER:PTN000669780|RGD:2479|RGD:631356|RGD:68945|UniProtKB:Q02928 1600115 GO_REF:0000033 GO_Central GO_REF:0000033 Cyp4a8 Rat arachidonate omega-hydroxylase activity enables IEA RHEA:39755 1600115 GO_REF:0000116 RHEA GO_REF:0000116 Cyp4a8 Rat fatty acid omega-hydroxylase activity enables IDA 2303409 PMID:15618658 UniProt Cyp4a8 Rat heme binding enables IEA InterPro:IPR001128|InterPro:IPR002401|InterPro:IPR036396 1600115 GO_REF:0000002 InterPro GO_REF:0000002 Cyp4a8 Rat iron ion binding enables IEA InterPro:IPR001128|InterPro:IPR002401|InterPro:IPR017972|InterPro:IPR036396 1600115 GO_REF:0000002 InterPro GO_REF:0000002 Cyp4a8 Rat metal ion binding enables IEA UniProtKB-KW:KW-0479 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Cyp4a8 Rat monooxygenase activity enables IDA 8554841 PMID:11139583 UniProt Cyp4a8 Rat monooxygenase activity enables IEA UniProtKB-KW:KW-0503 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Cyp4a8 Rat monooxygenase activity enables IEA InterPro:IPR001128|InterPro:IPR002401|InterPro:IPR036396 1600115 GO_REF:0000002 InterPro GO_REF:0000002 Cyp4a8 Rat oxidoreductase activity enables IEA UniProtKB-KW:KW-0560 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Cyp4a8 Rat oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen enables IEA InterPro:IPR001128|InterPro:IPR002401|InterPro:IPR017972|InterPro:IPR036396 1600115 GO_REF:0000002 InterPro GO_REF:0000002 Cyp4a8 Rat oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IEA RHEA:17149 1600115 GO_REF:0000116 RHEA GO_REF:0000116 Cyp4a8 Rat oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IEA EC:1.14.14.1 1600115 GO_REF:0000003 UniProt GO_REF:0000003 Cyp4a8 Rat oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IEA ARBA:ARBA00027735 1600115 GO_REF:0000117 UniProt GO_REF:0000117
Imported Annotations - KEGG (archival)
1.
The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands.
Cowart LA, etal., J Biol Chem. 2002 Sep 20;277(38):35105-12. Epub 2002 Jul 17.
2.
Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Dunn KM, etal., Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2455-65. Epub 2008 Oct 24.
3.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
4.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
5.
Covalently linked heme in cytochrome p4504a fatty acid hydroxylases.
Hoch U and Ortiz De Montellano PR, J Biol Chem. 2001 Apr 6;276(14):11339-46. Epub 2001 Jan 3.
6.
Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney.
Kroetz DL, etal., Mol Pharmacol. 1997 Sep;52(3):362-72.
7.
Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors.
Nguyen X, etal., Am J Physiol. 1999 Jun;276(6 Pt 2):R1691-700.
8.
Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.
Park F, etal., Am J Physiol Renal Physiol. 2009 Jan 7.
9.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
10.
GOA pipeline
RGD automated data pipeline
11.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
12.
Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension.
Singh H and Schwartzman ML, Pharmacol Rep. 2008 Jan-Feb;60(1):29-37.
13.
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
14.
Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate.
Stromstedt M, etal., DNA Cell Biol 1990 Oct;9(8):569-77.
15.
Contribution of CYP4A8 to the formation of 20-hydroxyeicosatetraenoic acid from arachidonic acid in rat kidney.
Yamaguchi Y, etal., Drug Metab Pharmacokinet. 2002;17(2):109-16.
16.
Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.
Zhou Y, etal., J Pharmacol Exp Ther. 2006 Apr;317(1):11-8. Epub 2005 Dec 8.
.
Predicted Target Of
Count of predictions: 94 Count of miRNA genes: 78 Interacting mature miRNAs: 81 Transcripts: ENSRNOT00000012448 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
1549845 Scl44 Serum cholesterol level QTL 44 6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 40128307 148607290 Rat 8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 111416838 156416838 Rat 1300122 Wbc1 White blood cell count QTL 1 2.75 leukocyte quantity (VT:0000217) total white blood cell count (CMO:0000365) 5 125392826 139989768 Rat 61452 Ciaa5 CIA Autoantibody QTL 5 3.5 blood autoantibody amount (VT:0003725) calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) 5 94858972 143070159 Rat 7411582 Foco3 Food consumption QTL 3 7.5 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 5 87468046 132468046 Rat 1302790 Scl20 Serum cholesterol level QTL 20 6.4 0.0001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 82394392 166664054 Rat 1598861 Cm64 Cardiac mass QTL 64 2.9 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 127798274 166875058 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 46711509 161317411 Rat 1549838 Bss4 Bone structure and strength QTL 4 9.2 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 5 106906205 151906205 Rat 2317753 Glom24 Glomerulus QTL 24 3.1 kidney glomerulus integrity trait (VT:0010546) kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) 5 97570330 136479578 Rat 7411564 Bw135 Body weight QTL 135 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 87468046 132468046 Rat 8694169 Bw148 Body weight QTL 148 5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 128506074 166875058 Rat 8657050 Bw146 Body weight QTL 146 19.84 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 108938288 153938288 Rat 1641912 Alcrsp18 Alcohol response QTL 18 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 5 35189153 141643988 Rat 2317056 Wbc3 White blood cell count QTL 3 2.51 0.01 leukocyte quantity (VT:0000217) white blood cell count (CMO:0000027) 5 105999803 150999803 Rat 724525 Bp147 Blood pressure QTL 147 4.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 126424772 166875058 Rat 2293642 Bss37 Bone structure and strength QTL 37 4.64 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 120740824 151018848 Rat 1578673 Bmd13 Bone mineral density QTL 13 4.9 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 5 103689353 148689353 Rat 70189 Mcs5 Mammary carcinoma susceptibility QTL 5 10.51 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 55805606 132207589 Rat 7207488 Bss110 Bone structure and strength QTL 1 8.4 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 5 106906205 151906205 Rat 8694441 Bw169 Body weight QTL 169 17.61 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 5 111416838 156416838 Rat 7207491 Bss112 Bone structure and strength QTL 112 7 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 5 106906205 151906205 Rat 2290448 Scl54 Serum cholesterol level QTL 54 2.93 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 31663789 131345958 Rat 8694198 Abfw3 Abdominal fat weight QTL 3 16.13 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 5 111416838 156416838 Rat 1298086 Bp156 Blood pressure QTL 156 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 84132602 129132602 Rat 1298089 Scl14 Serum cholesterol level QTL 14 5.8 0.0004 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 108845856 153845856 Rat 1331796 Thshl2 Thyroid stimulating hormone level QTL 2 2.3 blood thyroid-stimulating hormone amount (VT:0005119) serum thyroid stimulating hormone level (CMO:0001248) 5 97059760 147465714 Rat 10053720 Scort26 Serum corticosterone level QTL 26 2.06 0.0147 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 124965598 166875058 Rat 70212 Niddm25 Non-insulin dependent diabetes mellitus QTL 25 3.54 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 5 1 131345958 Rat 7365049 Bp359 Blood pressure QTL 359 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 128071929 134724733 Rat 1331801 Rf33 Renal function QTL 33 4.149 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 5 43726656 129132602 Rat 8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 6.6 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 128506074 166875058 Rat 61393 Bp7 Blood pressure QTL 7 4.5 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 60293434 161481680 Rat 7207486 Bss109 Bone structure and strength QTL 109 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 5 106906205 151906205 Rat 7207481 Bss106 Bone structure and strength QTL 106 7.9 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 106906205 151906205 Rat 1641920 Colcs1 Colorectal carcinoma susceptibility QTL 1 2.99 0.0055 intestine integrity trait (VT:0010554) benign colorectal tumor surface area measurement (CMO:0001799) 5 121846814 166846814 Rat 1581505 Rf54 Renal function QTL 54 kidney physiology trait (VT:0002136) kidney 20-HETE level (CMO:0001854) 5 128033842 133011550 Rat 1581510 Cm54 Cardiac mass QTL 54 3.4 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 5 120740824 143608494 Rat 1576312 Emca8 Estrogen-induced mammary cancer QTL 8 4.1 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 50328551 141643988 Rat 7411601 Foco12 Food consumption QTL 12 19.7 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 5 87468046 132468046 Rat 1576314 Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 2138965 166875058 Rat 7394710 Emca12 Estrogen-induced mammary cancer QTL 12 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 124160767 133749643 Rat 1598847 Cm62 Cardiac mass QTL 62 3.4 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 108845856 153845856 Rat 631527 Tls1 T-lymphoma susceptibility QTL 1 0 0.001 thymus integrity trait (VT:0010555) post-insult time to onset of T-cell lymphoma (CMO:0001907) 5 90450144 135450144 Rat 8694389 Bw160 Body weight QTL 160 6.17 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 5 111416838 156416838 Rat 61426 Scl2 Serum cholesterol level QTL 2 7.3 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 59793399 143070159 Rat 1354598 Srn6 Serum renin concentration QTL 6 3.8 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 5 69540295 151018848 Rat 1598819 Bp292 Blood pressure QTL 292 4.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 127798274 166875058 Rat 6903316 Bw113 Body weight QTL 113 2 0.0103 body mass (VT:0001259) body weight (CMO:0000012) 5 87765973 132765973 Rat 1358187 Emca1 Estrogen-induced mammary cancer QTL 1 4.4 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 5 99216724 148607142 Rat
RH135045
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 128,702,633 - 128,702,814 (+) MAPPER mRatBN7.2 Rnor_6.0 5 133,979,457 - 133,979,637 NCBI Rnor6.0 Rnor_5.0 5 137,770,369 - 137,770,549 UniSTS Rnor5.0 RGSC_v3.4 5 135,547,362 - 135,547,542 UniSTS RGSC3.4 Celera 5 127,340,920 - 127,341,100 UniSTS RH 3.4 Map 5 828.6 UniSTS Cytogenetic Map 5 q36 UniSTS
AA893011
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 128,702,186 - 128,702,420 (+) MAPPER mRatBN7.2 Rnor_6.0 5 133,979,010 - 133,979,243 NCBI Rnor6.0 Rnor_5.0 5 137,769,922 - 137,770,155 UniSTS Rnor5.0 RGSC_v3.4 5 135,546,915 - 135,547,148 UniSTS RGSC3.4 Celera 5 127,340,473 - 127,340,706 UniSTS RH 3.4 Map 5 836.0 UniSTS Cytogenetic Map 5 q36 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
8
10
17
47
78
76
47
25
47
5
166
61
28
42
37
29
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000012448 ⟹ ENSRNOP00000012448
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 128,702,131 - 128,733,476 (-) Ensembl Rnor_6.0 Ensembl 5 133,978,954 - 134,008,255 (-) Ensembl
RefSeq Acc Id:
NM_031605 ⟹ NP_113793
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 133,938,882 - 133,970,226 (-) NCBI mRatBN7.2 5 128,702,130 - 128,733,476 (-) NCBI Rnor_6.0 5 133,978,953 - 134,008,255 (-) NCBI Rnor_5.0 5 137,769,865 - 137,799,167 (-) NCBI RGSC_v3.4 5 135,546,858 - 135,578,199 (-) RGD Celera 5 127,340,416 - 127,371,735 (-) RGD
Sequence:
GAAGCTGTGGTATCATGAGTGGCTCGGCTCTGAGCTTCACCATATTCCCAGGAAGTATCCTTGGGTTCCTCCAAATAGCCACTGTGCTCACTGTGCTCCTGCTGCTCTTCAAGACAGCCCAGTTCTAC CTGCACAGGCGATGGTTACTCAGAGCTACCCAGCAGTTCCCATCCCCACCTTCTCACTGGTTCTTTGGGCATAAGATCCCAAAGGACCAGGAGTTTCAAGATATTCTAACACGGGTAAAGAATTTCCC AAGTGCCTGTCCACAGTGGCTCTGGGGGAGCAATGTGCGAATCCAAGTGTATGACCCTGACTACATGAAGCTGATTCTGGGGAGATCAGACCCAAAATCCCATCATTCGTACAGATTTCTAGCTCCCT GGATTGGGTATGGTTTGCTTCTGCTGAATGGACAGACATGGTTCCAGCACCGACGAATGTTGACTCCAGCTTTCCACTATGACACTCTGAAACCTTATGTGGGCATCATGGCAGACTCTGTTCGTATA ATGCTGGATAAATGGGAACAGATTGTTGGACAGGATTCCACCCTGGAGATCTTCCAACACATCACCTTGATGACCTTGGACACCATCATGAAGTGTGCCTTCAGCCAAGAGGGCAGTGTCCAGTTGGA CAGAAAATACAAGTCCTACATCAAGGCAGTTGAGGACCTGAACAATCTCTCTTTTTTCCGTATACGGAACATCTTTCACCAGAATGACATCATCTATAGTCTGTCCTCTAATGGCCGCAAGGCCCGCA GTGCCTGGCAACTTGCCCATGAGCACACAGACCAAGTGATCAAATCAAGGAAGGCTCAACTTCAGGACGAGGAAGAGTTGCAAAAGGTTAAGCAGAAAAGACGATTGGATTTCCTGGACATCCTTCTG TTTGCCAGAATAGAAAATGGAAGCAGCTTATCTGATAAGGACCTGCGTGCTGAAGTGGATACCTTCATGTTCGAGGGCCATGACACCACAGCTAGCGGTATCTCTTGGATCTTCTATGCTTTGGCCAC AAATCCTGAACACCAGCAGGGATGCAGGAAGGAGATCCAGAGTCTCCTAGGAGATGGAGCTTCTATCACCTGGGACGACCTGGACAAGATGCCCTACACCACCATGTGCATCAAGGAAGCTCTGAGGA TCTACCCACCTGTAACAGCTGTGAGCAGAATGCTCAGCACACCTGTCACCTTCCCGGATGGACGCTCTTTACCCAAAGGTATCACAGTCATGCTCTCCTTCTATGGCCTTCATCACAACCCAACTGTG TGGCCAAATCCAGAGGTGTTTGACCCTTATCGATTTGCACCAGAGTCTTCCCGACACAGCCACTCATTCCTGCCCTTCTCAGGAGGAGCAAGGAACTGCATTGGGAAACAGTTTGCCATGAATGAACT GAAGGTGGCCGTGGCCCTGACCCTGCTCCGCTTTGAGCTGCTGCCAGATCCCACCAGGATCCCAATCCCCATACCAAGACTCGTGTTGAAGTCCAAGAATGGGATCTACCTGCGTCTCAAAAAGCTCC AATAATCTTGACAGCACAAGACAGCTCCAACAGCATGCTGTCTGCCATTTGTCTTTCTGTCAGTCACTCTTGTCCCCACTCCATCTGCTCACATCTCATTCTTTCTTCTCACCTTGTTCACCTCCACC CACCTTCTGCTGTGCTTCTGGTCTCCTTGTCTGTCAGTCTTTCTATCTCGACTTCTGGAATTTCTACCTGCTTTTCTCTCTACCTGGCCCCTACCTGACTTCATGTTTGACCTTGACCTTAATGATCT CCCTAAATTACACCCTGCCTTCTCTTCTGCATATTTCCTTCTATTCTACTGTTTGTCTGTGCTTAAATTGAGCTTTATACCAATGTCATAATTGATTACAATAGAAGTATTGCCCTATGATTCGATAT ACCAGGTGTTTTTCATGATTTCATTAGAATAAAGCTCAGGTCATTGCAGTACCATTGCCCTTGGTTATTTCTGTGACTCTTTTTACCTTTTCCATCACCTATAGCTGCATTCCTAGGTTGCAAGAGCC TGTCTGAGTGTTAAAATCCAACATTGTCTTTAAGCACGTCTTATTCTGTCTCTAGGTCATCTCTTCATCTTGTCAATATGTATGCTTACTTTGTGCTTAAGTGGTAATACTGGTCATGTTCTTGGTTC TGTCAAAGAGCCATTGTTCCAGCAACCTAACACAGTCCTTCTCTGACTGTCACCTCATCTATCCATATAAATCTCACCTTCAAAAACTCTGCCTACCAGCTTTAAGAGTCTTACCATCGCCCCAGTGA ACGTGATTGTTGCGGGGAGGGCGGCAATGGGTGAAGGATGGGGAGGGGAACACCCGTAAAGAAGGGGAGGGGGAAGAGTTAGGGGGATGTTGGCCCGGAAACCAGGAAAGGGAATAACACTCAAAATG TAAATAAGAAATACTCAAGTTAATAAAAAAAAAAGAGTCTTGTCAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NP_113793 ⟸ NM_031605
- UniProtKB:
Q642E9 (UniProtKB/Swiss-Prot), P24464 (UniProtKB/Swiss-Prot)
- Sequence:
MSGSALSFTIFPGSILGFLQIATVLTVLLLLFKTAQFYLHRRWLLRATQQFPSPPSHWFFGHKIPKDQEFQDILTRVKNFPSACPQWLWGSNVRIQVYDPDYMKLILGRSDPKSHHSYRFLAPWIGYG LLLLNGQTWFQHRRMLTPAFHYDTLKPYVGIMADSVRIMLDKWEQIVGQDSTLEIFQHITLMTLDTIMKCAFSQEGSVQLDRKYKSYIKAVEDLNNLSFFRIRNIFHQNDIIYSLSSNGRKARSAWQL AHEHTDQVIKSRKAQLQDEEELQKVKQKRRLDFLDILLFARIENGSSLSDKDLRAEVDTFMFEGHDTTASGISWIFYALATNPEHQQGCRKEIQSLLGDGASITWDDLDKMPYTTMCIKEALRIYPPV TAVSRMLSTPVTFPDGRSLPKGITVMLSFYGLHHNPTVWPNPEVFDPYRFAPESSRHSHSFLPFSGGARNCIGKQFAMNELKVAVALTLLRFELLPDPTRIPIPIPRLVLKSKNGIYLRLKKLQ
hide sequence
Ensembl Acc Id:
ENSRNOP00000012448 ⟸ ENSRNOT00000012448
RGD ID: 13693916
Promoter ID: EPDNEW_R4441
Type: multiple initiation site
Name: Cyp4a8_1
Description: cytochrome P450, family 4, subfamily a, polypeptide 8
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 5 134,008,268 - 134,008,328 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2007-07-06
Cyp4a8
cytochrome P450, family 4, subfamily a, polypeptide 8
Cyp4a12
cytochrome P450, 4a12
Name updated
1299863
APPROVED
2003-02-27
Cyp4a12
cytochrome P450, 4a12
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_regulation
expression is induced by androgen treatment of castrated rats
70705